Physician profile
Deniz S Basci
NPI 1194084327
$6,240.33
in general payments reported to CMS, 2019-2025
17 companies · $548 in 2025
The $548 reported for 2025 was more than what 75% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,740 · 2020: $480 · 2021: $625 · 2022: $908 · 2023: $542 · 2024: $397 · 2025: $548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,487.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,187.12 | 2019-2022 | |
| Galderma Laboratories, L.P. | $1,000.00 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $745.27 | 2019 | |
| Abbvie INC. | $627.63 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Stryker Corporation | $567.66 | 2019 | |
| Davol INC. | $482.04 | 2022-2025 | Phasix Mesh |
| Sientra, INC. | $322.62 | 2022 | |
| Mentor Worldwide LLC | $277.34 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Bard Peripheral Vascular, INC. | $257.73 | 2021 | |
| Solta Medical, A Division of Bausch Health US, LLC | $197.89 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $121.71 | 2019-2024 | Exparel |
| Motiva USA, LLC | $114.21 | 2025 | |
| Kls-Martin L.P. | $97.85 | 2019 | |
| Rti Surgical, INC | $83.33 | 2024 | |
| Axogen | $76.00 | 2022-2024 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $44.51 | 2020 | |
| Integra Lifesciences Corporation | $37.42 | 2022-2023 | Durasorb Monofilament Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deniz Basci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.